POLISCOPE
Back to bills

The civic record

Read. Follow. Verify.
Passed

Missouri House Bill 2033 prohibits gender transition surgeries, cross-sex hormones, and puberty-blocking…

Original title: GENDER TRANSITION PROCEDURES

Last action · April 8, 2026: Voted Do Pass (S)Sponsors: Melissa Schmidt and 13 others

Introduced
Committee
Floor Vote
Passed
Law

Track this bill to get notified when it advances a stage. One tap to stop, anytime.

Public stanceCommunity reactions are separate from the official record and reporting.

What This Bill Would Do

Missouri House Bill 2033 prohibits health care providers from performing gender transition surgeries or prescribing and to individuals under 18 years of age. Violations constitute unprofessional conduct resulting in license revocation, and the bill establishes a civil cause of action for injured individuals with a minimum damage threshold of $500,000, tripled upon judgment. An exception is provided until March 1, 2027, for minors who began receiving such hormone or drug treatments prior to August 28, 2023.

Why it matters

Minors under 18 lose access to specified gender transition procedures and medications, while health care providers face mandatory license revocation and civil liability with uncapped damages and mandatory minimums starting at $500,000.

Who It Would Affect

Groups the bill's text would affect if enacted, as described in the record. Being affected is not a position for or against it.

Directly affected

Health care provider

Health care providers are prohibited from performing certain surgeries or prescribing specific medications to minors, face mandatory license revocation for violations, and are subject to civil lawsuits with mandatory minimum damages.

Directly affected

Individuals under eighteen years of age

Minors are prohibited from receiving gender transition surgeries, cross-sex hormones, or puberty-blocking drugs, and are granted specific rights to bring civil actions against providers within a defined timeframe.

Key Facts

  • Health care providers are prohibited from knowingly performing gender transition surgeries on any individual under eighteen years of age.
  • Health care providers are prohibited from knowingly prescribing or administering cross-sex hormones or puberty-blocking drugs for the purpose of a gender transition to any individual under eighteen years of age.
  • Until March 1, 2027, the ban on prescribing or administering cross-sex hormones or puberty-blocking drugs does not apply to minors who were prescribed or administered such treatments prior to August 28, 2023.
  • Violations of the restrictions are considered unprofessional conduct, requiring the appropriate licensing entity to revoke the health care provider's license.
Show all 11 facts
  • The bill establishes a civil cause of action against health care providers who prescribe or administer cross-sex hormones or puberty-blocking drugs to minors, exempting these actions from chapter 538.
  • Civil actions may be brought within fifteen years of the injured individual attaining the age of twenty-one or of the date the treatment ceased, whichever is later.
  • Plaintiffs in civil actions are entitled to a rebuttable presumption of harm if they are infertile following hormone or drug treatment, rebuttable only by clear and convincing evidence.
  • Plaintiffs may recover economic, noneconomic, and punitive damages without limitation, with an aggregate minimum of five hundred thousand dollars, tripled upon final judgment, plus attorney's fees and court costs.
  • Health care providers are barred from requiring a waiver of the right to bring an action as a condition of services, and parents or legal guardians cannot waive a minor's right to sue.
  • Settlements require court approval, prohibit confidentiality provisions unless requested by the plaintiff, and permit the protection of the plaintiff's personal identifying information.
  • Exceptions to the restrictions include protections for speech under the First Amendment, services for individuals with medically-verifiable disorders of sex development, treatments for infections or injuries caused by prior procedures, and emergency procedures certified by a physician to prevent imminent death or impairment.

Frequently Asked Questions

Who is restricted from receiving gender transition surgeries or hormones under this bill?
Any individual under eighteen years of age is restricted from receiving gender transition surgeries, , or for the purpose of a gender transition.
What happens to a health care provider who violates these restrictions?
The violation is considered unprofessional conduct, and the health care provider's license to practice must be revoked by the appropriate licensing entity or disciplinary review board. They also face potential civil liability with mandatory minimum damages.
Are there any exceptions for minors who were already receiving hormone or puberty-blocking treatments?
Yes. Until March 1, 2027, the restrictions on prescribing or administering or do not apply to individuals under eighteen who were prescribed or administered those treatments prior to August 28, 2023.
What damages can a plaintiff recover in a civil action brought under this measure?
A plaintiff may recover economic, noneconomic, and punitive damages without limitation, with an aggregate minimum of five hundred thousand dollars. The final judgment is assessed at three times the total assessed damages, plus attorney's fees and court costs.

What else do you want to know?

News Coverage

No news coverage found yet. Articles are indexed twice daily.

Where This Stands

Currently passed chamber. The next step in the legislative lifecycle is Law.

Procedural history

25 actions
  1. Apr 8, 2026SenateCommittee
    Voted Do Pass (S)
  2. Apr 8, 2026Senate
    Executive Session Held (S)
  3. Mar 25, 2026Senate
    Public Hearing Held (S)
  4. Mar 23, 2026Senate
    Public Hearing Scheduled (S)
  5. Feb 26, 2026SenateCommittee
    Second read and referred: Families, Seniors and Health(S)
  6. Feb 17, 2026Senate
    Reported to the Senate and First Read (S)
Show 19 earlier actions
  1. Feb 12, 2026HouseFloor
    Third Read and Passed (H)
  2. Feb 12, 2026House
    Taken Up for Third Reading (H)
  3. Feb 9, 2026House
    Perfected (H)
  4. Feb 9, 2026House
    HCS Adopted (H)
  5. Feb 9, 2026House
    Title of Bill - Agreed To
  6. Feb 9, 2026House
    Taken Up for Perfection (H)
  7. Feb 4, 2026House
    Placed on the Informal Perfection Calendar (H)
  8. Feb 2, 2026HouseCommittee
    Reported Do Pass (H)
  9. Feb 2, 2026HouseCommittee
    Voted Do Pass (H)
  10. Feb 2, 2026House
    Executive Session Completed (H)
  11. Jan 29, 2026HouseCommittee
    Referred: Rules - Legislative(H)
  12. Jan 28, 2026HouseCommittee
    HCS Reported Do Pass (H)
  13. Jan 27, 2026HouseCommittee
    HCS Voted Do Pass (H)
  14. Jan 27, 2026House
    Executive Session Completed (H)
  15. Jan 20, 2026House
    Public Hearing Completed (H)
  16. Jan 12, 2026HouseCommittee
    Referred: Emerging Issues(H)
  17. Jan 8, 2026HouseFloor
    Read Second Time (H)
  18. Jan 7, 2026HouseIntroduced
    Read First Time (H)
  19. Dec 1, 2025HouseIntroduced
    Prefiled (H)

Version history

Only one version on file - nothing to compare yet. As later stages (committee substitute, engrossed, enrolled) are captured, the redline appears here.

View official text →

Lobbying Activity

No state lobbying filings in our records match this bill. Federal lobbying reports (LDA) cover Congress, so they are not listed on state bills.

Full breakdown

Who this bill affects and the strongest case for and against it, written only from the bill’s own text.

Sponsors

Connected Entities

Bob Titus, Bill Irwin, Lisa Durnell and 8 more
PersonBob Titus“Co-sponsor (District 139)”Map →
PersonBill Irwin“Co-sponsor (District 055)”Map →
PersonLisa Durnell“Co-sponsor (District 154)”Map →
PersonJohn Simmons“Co-sponsor (District 109)”Map →
PersonSteve Jordan“Co-sponsor (District 151)”Map →
PersonBurt Whaley“Co-sponsor (District 138)”Map →
PersonBrian Seitz“Co-sponsor (District 156)”Map →
PersonDeanna Self“Co-sponsor (District 064)”Map →
PersonMelissa Schmidt“Representative (District 141) who introduced HB 2033”Map →
PersonJohn Hewkin“Co-sponsor (District 120)”Map →
PersonBill Hardwick“Co-sponsor (District 121)”Map →

Sources

Analysis Score

0–100
  • Significance90
    How much this matters to a regular citizen
  • Controversy95
    Intensity of disagreement among stakeholders
  • Entertainment10
    Compellingness for a non-policy-wonk reader
  • Buzz85
    Current news / social attention level

Publisher tools

Share or embed this record

POLISCOPE publisher tools

Share or embed this record